Apheresis Market Overview
The Apheresis Market focuses on medical procedures, devices, systems, and consumables used to separate specific components of blood from whole blood. Apheresis technologies are used for both therapeutic and donor applications, allowing healthcare professionals to selectively collect or remove plasma, platelets, red blood cells, white blood cells, or other blood components. The technology plays an important role in the management of various hematological, neurological, autoimmune, renal, and oncological conditions, while also supporting the collection of blood components and plasma derivatives. According to Market Research Future, the global Apheresis Market was valued at USD 1.2 billion in 2024 and is projected to grow from USD 1.308 billion in 2025 to approximately USD 3.097 billion by 2035, registering a CAGR of 9.0% during the forecast period 2025–2035.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/1508
Market Drivers
Increasing Prevalence of Chronic and Blood-Related Disorders:
The increasing prevalence of chronic diseases, hematological disorders, autoimmune diseases, neurological disorders, and renal conditions is driving demand for apheresis procedures. Apheresis can be used as part of treatment strategies for conditions where specific blood components need to be removed, replaced, or collected, creating continued demand for therapeutic apheresis technologies.
Rising Demand for Blood Components:
The growing need for plasma, platelets, and other blood components is supporting the adoption of donor apheresis procedures. Apheresis enables blood centers to collect targeted components efficiently, helping improve blood-component availability and supporting transfusion medicine.
Growing Demand for Plasma Derivatives:
Increasing demand for plasma-derived products is contributing to the expansion of plasma collection activities. The growing use of plasma-based therapies in the treatment of various medical conditions is creating opportunities for plasma apheresis equipment and related consumables.
Technological Advancements in Apheresis Systems:
Advancements in automated apheresis equipment are improving collection efficiency, procedure control, and patient convenience. Modern systems increasingly incorporate automation, improved monitoring capabilities, enhanced separation technologies, and user-friendly interfaces, supporting wider adoption in hospitals and blood collection centers.
Increasing Adoption of Therapeutic Apheresis:
Therapeutic apheresis is gaining importance in the management of selected autoimmune, neurological, hematological, and renal disorders. The ability to selectively remove unwanted components from blood makes therapeutic apheresis an important option in specialized medical care.
Regulatory Support and Blood Donation Initiatives:
Government initiatives supporting blood donation, plasma collection, blood safety, and transfusion services are contributing to market expansion. Increasing awareness regarding blood donation and improvements in blood collection infrastructure are also supporting demand for apheresis technologies.
Market Challenges
High Cost of Apheresis Equipment:
Apheresis machines and associated technologies can require substantial capital investment. The high cost of equipment, maintenance, and specialized consumables can limit adoption among smaller hospitals, blood centers, and healthcare facilities with constrained budgets.
High Cost of Consumables:
Apheresis procedures frequently require specialized disposable kits and other consumables. The recurring cost of these products can increase the overall cost of treatment and blood-component collection, particularly in healthcare systems with limited reimbursement.
Requirement for Skilled Healthcare Professionals:
Apheresis procedures require trained healthcare professionals who understand blood separation technologies, patient monitoring, anticoagulation management, and potential procedural complications. Limited availability of appropriately trained personnel can restrict adoption in some developing regions.
Risk of Procedure-Related Complications:
Although apheresis is widely used, procedures may involve complications such as hypotension, citrate-related reactions, allergic reactions, vascular-access problems, or other adverse events. Appropriate patient selection and professional monitoring are essential.
Limited Access to Advanced Healthcare Infrastructure:
The availability of advanced apheresis systems remains uneven across regions. Hospitals and blood centers in emerging economies may face challenges related to equipment costs, specialized personnel, infrastructure, and access to maintenance services.
Browse In-depth Market Research Report on Apheresis Market:
https://www.marketresearchfuture.com/reports/apheresis-market-1508
Market Segmentation
By Product Type:
Therapeutic Apheresis: Therapeutic apheresis systems are used to remove specific blood components from patients as part of treatment for selected diseases and medical conditions.
Donor Apheresis: Donor apheresis systems are used to collect specific blood components such as plasma or platelets from healthy donors.
Plasma Apheresis: Plasma apheresis focuses on the collection or separation of plasma and is increasingly important because of the growing demand for plasma-derived therapies.
Cell Apheresis: Cell apheresis involves the collection or separation of specific cellular components, including platelets and other blood cells, for therapeutic or transfusion applications.
By Application:
Renal Disorders: Apheresis technologies may be used in selected renal-related conditions where removal of specific circulating components is clinically appropriate.
Neurological Disorders: Therapeutic apheresis is used in the management of certain neurological and neuromuscular disorders, supporting demand from specialized healthcare facilities.
Cancer Treatment: Apheresis can play a role in selected oncology and hematology applications, including procedures involving specific blood-cell populations.
Autoimmune Disorders: The use of therapeutic plasma exchange and other apheresis techniques in selected autoimmune conditions is supporting demand for specialized systems.
By End User:
Hospitals: Hospitals represent a major end user because they provide specialized therapeutic apheresis procedures and manage patients with complex medical conditions.
Blood Donation Centers: Blood donation centers use apheresis technologies to collect specific blood components efficiently from donors.
Research Laboratories: Research laboratories utilize apheresis-related technologies for specialized research, blood-component studies, and development activities.
By Procedure Type:
Manual Apheresis: Manual procedures involve greater dependence on healthcare professionals and may be used in specific clinical or resource-limited settings.
Automated Apheresis: Automated apheresis systems use advanced equipment to control blood separation and component collection, improving consistency, efficiency, and procedural management.
By Region:
North America: North America is the leading regional market, supported by advanced healthcare infrastructure, high adoption of medical technologies, established blood collection systems, and strong demand for therapeutic apheresis.
Europe: Europe represents an important market due to developed healthcare systems, increasing demand for blood components, and growing adoption of advanced transfusion and therapeutic technologies.
Asia-Pacific: Asia-Pacific is emerging as a rapidly growing market, supported by increasing healthcare investments, rising awareness, expanding blood collection infrastructure, and the growing prevalence of chronic diseases.
Latin America, Middle East & Africa: These regions represent emerging opportunities as healthcare infrastructure improves, blood donation programs expand, and access to specialized medical procedures increases.
Regional Insights
North America:
North America is expected to maintain a leading position in the Apheresis Market. The region benefits from advanced healthcare infrastructure, established blood donation networks, high adoption of automated medical technologies, and increasing demand for therapeutic procedures. The United States represents a major market due to its sophisticated healthcare system and strong demand for blood components and plasma-derived products.
Europe:
Europe is supported by established healthcare infrastructure and growing demand for blood-component collection and therapeutic apheresis. Countries such as Germany, France, the UK, and other European nations are investing in advanced medical technologies and blood-management systems. Increasing healthcare requirements associated with aging populations are also supporting market demand.
Asia-Pacific:
Asia-Pacific is expected to witness strong market growth during the forecast period. Increasing healthcare expenditure, expanding hospital infrastructure, rising awareness of blood donation, and the growing prevalence of chronic diseases are contributing to demand. China, Japan, India, and other emerging economies are investing in modern healthcare technologies and blood collection infrastructure.
Rest of the World:
Latin America, the Middle East, and Africa are expected to offer emerging growth opportunities. Improvements in healthcare infrastructure, increasing awareness of blood donation, expansion of hospitals and blood centers, and greater access to specialized treatments are likely to support adoption of apheresis technologies.
Key Players
- Terumo
- Fresenius Kabi
- Haemonetics
- Grifols
- Octapharma
- Cellerant Therapeutics
- Kedrion
- Blood Centers of America
- Asahi Kasei
Future Outlook
The Apheresis Market is expected to experience significant growth through 2035, supported by technological advancements, increasing demand for blood components, rising prevalence of chronic and autoimmune diseases, and growing demand for plasma-derived products. Market Research Future projects the market to reach approximately USD 3.097 billion by 2035, registering a CAGR of 9.0% from 2025 to 2035.
The development of advanced automated apheresis systems is expected to remain a major opportunity for manufacturers. Automation can improve operational efficiency, enhance procedural control, and support consistent blood-component collection. The expansion of apheresis services beyond major hospitals, including blood donation centers and selected outpatient healthcare settings, may further broaden market opportunities.
Increasing investments in plasma collection infrastructure are also expected to support the market. As demand for plasma-derived therapies increases, healthcare organizations and blood collection facilities are likely to expand their capabilities for plasma collection and processing.
In addition, technological improvements focused on patient safety, real-time monitoring, disposable-system design, and improved separation efficiency are expected to shape the next generation of apheresis technologies. The combination of increasing clinical applications and growing demand for blood components is expected to create sustained opportunities for manufacturers and healthcare providers.
Gain valuable insights through comprehensive industry analysis:
Clinical Trial Management System Market Volume
Clinical Trial Management System Market Forecast
Clinical Trial Management System Market Outlook
Cosmetic Dentistry Market Analysis
Cosmetic Dentistry Market Distribution
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country-level market segments enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
